Autopsy report · NCT05193370

Angiotensin II vs. Vasopressin in Septic Shock

“Funding and protocol changes. Replaced with new pilot trial.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University of New Mexico

Sponsor type

University, hospital or other

Conditions

Septic Shock

Interventions

Angiotensin II; Vasopressin

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• BreathID Multi-center HCV Liver Breath Test Study
  “Due to FDA comments, protocol changed; new trial will be proposed shortly” (70% match in meaning)
• Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.
  “Initial version of the protocol not submitted and new version approved has a new sponsor and it has been added into Clinicaltrials by the new sponsor” (68% match in meaning)
• Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks
  “Funding changes.” (67% match in meaning)
• Optimized Caloric-proteic Nutrition in Septic and Septic Shock Patients
  “The protocol was modified substantially and will be resubmitted to Clinical Trial” (67% match in meaning)
• Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.
  “Study was redeveloped into a new protocol” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.